Artivion Inc
General ticker "AORT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.2B
Artivion Inc follows the US Stock Market performance with the rate: 68.4%.
Estimated limits based on current volatility of 1.5%: low 27.76$, high 28.63$
Factors to consider:
- US accounted for 50.7% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [14.81$, 25.98$]
- 2024-12-30 to 2025-12-30 estimated range: [18.73$, 31.01$]
Financial Metrics affecting the AORT estimates:
- Positive: 0.10 < Non-GAAP EPS, $ of 0.21
- Negative: negative Net income
- Positive: 1.03 < Operating profit margin, % of 1.56
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: Inventory ratio change, % of 4.47 > 1.08
- Negative: Industry operating profit margin (median), % of -26.46 <= 2.14
Short-term AORT quotes
Long-term AORT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $314.76MM | $313.79MM | $368.25MM |
| Operating Expenses | $306.64MM | $307.59MM | $362.51MM |
| Operating Income | $8.12MM | $6.20MM | $5.74MM |
| Non-Operating Income | $-22.94MM | $-21.18MM | $-27.33MM |
| Interest Expense | $16.89MM | $18.22MM | $25.30MM |
| R&D Expense | $35.55MM | $38.88MM | $28.71MM |
| Income(Loss) | $-14.83MM | $-14.98MM | $-21.59MM |
| Taxes | $0.01MM | $4.21MM | $9.10MM |
| Profit(Loss) | $-14.83MM | $-19.19MM | $-30.69MM |
| Stockholders Equity | $300.73MM | $284.33MM | $281.78MM |
| Inventory | $76.97MM | $74.48MM | $81.98MM |
| Assets | $793.05MM | $762.80MM | $792.40MM |
| Operating Cash Flow | $-2.58MM | $-5.15MM | $18.82MM |
| Capital expenditure | $13.09MM | $10.71MM | $7.43MM |
| Investing Cash Flow | $5.66MM | $-10.71MM | $-0.50MM |
| Financing Cash Flow | $-12.22MM | $-1.64MM | $0.86MM |
| Earnings Per Share* | $-0.38 | $-0.48 | $-0.75 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.